Evidence map›Paper›PMID 41594663›Full record

ArticleBiomolecules2026

Structural Basis of Chemokine CXCL8 Monomer and Dimer Binding to Chondroitin Sulfate: Insights into Specificity and Plasticity.

Bryon P Mahler, Balaji Nagarajan, Nehru Viji Sankaranarayanan, Prem Raj B Joseph, Umesh R Desai, Krishna Rajarathnam

Abstract read
In one paragraph

Article in Biomolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Bryon P MahlerDepartment of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555, USA.ORCID 0000-0003-0307-5166
Balaji NagarajanCenter for Drug Discovery, Department of Medicinal Chemistry, Virginia Commonwealth University, Richmond, VA 23219, USA.
Nehru Viji SankaranarayananCenter for Drug Discovery, Department of Medicinal Chemistry, Virginia Commonwealth University, Richmond, VA 23219, USA.ORCID 0000-0002-2870-9164
Prem Raj B JosephDepartment of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555, USA.
Umesh R DesaiCenter for Drug Discovery, Department of Medicinal Chemistry, Virginia Commonwealth University, Richmond, VA 23219, USA.ORCID 0000-0002-1976-6597
Krishna RajarathnamDepartment of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555, USA.ORCID 0000-0002-0077-700X

Funding

Project 3: Role of Glycosaminoglycans in HematopoiesisP01HL151333 · NHLBI · VERSITI WISCONSIN, INC. · PI HOFFMEISTER, KARIN MARIA · 2021 to 2025
$12.3M
Chemokine Synergy and Neutrophil FunctionR21AI124681 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI RAJARATHNAM, KRISHNA · 2016 to 2017
$426k
High Performance Computing Cluster for Biomedical Research at VCUS10RR027411 · NCRR · VIRGINIA COMMONWEALTH UNIVERSITY · PI CUI, MENG · 2010 to 2010
$417k
NCRR NIH HHS S10 RR027411NHLBI NIH HHS P01 HL151333NIAID NIH HHS R21 AI124681
6 · The paper itself

Abstract

Chemokines play a central role in orchestrating neutrophil recruitment from the bloodstream and determining their effector functions at sites of infection. Chemokine activity is determined by three key properties: reversible monomer-dimer equilibrium, binding to glycosaminoglycans (GAGs), and signaling through the GPCR class of receptors CXCR1 and CXCR2. In this study, we investigated the structural basis of CXCL8 monomer and dimer binding to GAG chondroitin sulfate (CS) using nuclear magnetic resonance (NMR) spectroscopy, docking, and molecular dynamics (MD) measurements. Our studies reveal that both the monomer and dimer use essentially the same set of basic residues for binding, that the interface is extensive, that the dimer is the high-affinity CS ligand, and that the CS-binding residues form a contiguous surface within a monomer. Several of these residues also participate in receptor interactions, suggesting that CS-bound CXCL8 is likely impaired in its ability to bind receptors. Notably, we observe that the same basic residues are involved in binding CS and heparin/heparan sulfate, even though these GAGs differ in backbone structures and sulfation patterns. We conclude that the strategic distribution and topology of basic residues on the CXCL8 scaffold enable engagement with diverse GAG structures, which likely allows fine-tuning receptor signaling to regulate neutrophil trafficking and effector functions.

Indexed as

Chondroitin SulfatesInterleukin-8Binding SitesHumansMagnetic Resonance SpectroscopyMolecular Docking SimulationMolecular Dynamics SimulationProtein BindingProtein MultimerizationChondroitin SulfatesCXCL8 protein, humanInterleukin-8chemokinechondroitin sulfateCXCL8glycosaminoglycanheparan sulfateheparininterleukin-8molecular dynamicsneutrophilnuclear magnetic resonanceproteoglycan

Identifiers

PMID41594663
PMCPMC12838738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.